Cargando…

Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma

BACKGROUND: Anastomotic stenosis and leakage are rare complications after esophagojejunostomy. The management of complications after esophagojejunostomy remains a challenge. We evaluated the outcomes and clinical effectiveness of an alternative interventional protocol. OBJECTIVES: To determine the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yonghua, Li, Jindong, Yi, Mengfei, Yu, Zepeng, Han, Xinwei, Ren, Jianzhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913380/
https://www.ncbi.nlm.nih.gov/pubmed/31871443
http://dx.doi.org/10.1155/2019/1465301
_version_ 1783479650992783360
author Bi, Yonghua
Li, Jindong
Yi, Mengfei
Yu, Zepeng
Han, Xinwei
Ren, Jianzhuang
author_facet Bi, Yonghua
Li, Jindong
Yi, Mengfei
Yu, Zepeng
Han, Xinwei
Ren, Jianzhuang
author_sort Bi, Yonghua
collection PubMed
description BACKGROUND: Anastomotic stenosis and leakage are rare complications after esophagojejunostomy. The management of complications after esophagojejunostomy remains a challenge. We evaluated the outcomes and clinical effectiveness of an alternative interventional protocol. OBJECTIVES: To determine the safety and efficacy of interventional treatment for the management of complications after esophagojejunostomy. METHODS: This study included 24 consecutive patients with complications after esophagojejunostomy treated using interventional protocol. Patients received balloon dilation or stenting for anastomotic stenosis. Patients with anastomotic leakage received three-tube placement or retrievable covered esophageal stent placement, followed by abscess drainage, nutritional support, and anti-inflammatory treatment. The three tubes and esophageal stents were removed after leakage healing and stenosis ceased. RESULTS: Thirteen patients received three-tube method, and 16 patients received covered stent placement. All procedures were technically successful, except for a failure of Y-type esophageal stent placement in one patient. The median retention time of stent and abscess drainage tube was 67.5 days and 87 days, respectively. No perioperative death, esophageal rupture, or massive hemorrhage was found during procedures. During follow-up, 14 patients died of cancer recurrence, and one died of severe pulmonary infection. The 1-, 3-, 5-year survival rates were 39.5%, 23.7%, and 23.7%, respectively. CONCLUSION: Interventional protocol is safe, feasible, and efficacious for treatment of complications after esophagojejunostomy.
format Online
Article
Text
id pubmed-6913380
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69133802019-12-23 Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma Bi, Yonghua Li, Jindong Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang Gastroenterol Res Pract Clinical Study BACKGROUND: Anastomotic stenosis and leakage are rare complications after esophagojejunostomy. The management of complications after esophagojejunostomy remains a challenge. We evaluated the outcomes and clinical effectiveness of an alternative interventional protocol. OBJECTIVES: To determine the safety and efficacy of interventional treatment for the management of complications after esophagojejunostomy. METHODS: This study included 24 consecutive patients with complications after esophagojejunostomy treated using interventional protocol. Patients received balloon dilation or stenting for anastomotic stenosis. Patients with anastomotic leakage received three-tube placement or retrievable covered esophageal stent placement, followed by abscess drainage, nutritional support, and anti-inflammatory treatment. The three tubes and esophageal stents were removed after leakage healing and stenosis ceased. RESULTS: Thirteen patients received three-tube method, and 16 patients received covered stent placement. All procedures were technically successful, except for a failure of Y-type esophageal stent placement in one patient. The median retention time of stent and abscess drainage tube was 67.5 days and 87 days, respectively. No perioperative death, esophageal rupture, or massive hemorrhage was found during procedures. During follow-up, 14 patients died of cancer recurrence, and one died of severe pulmonary infection. The 1-, 3-, 5-year survival rates were 39.5%, 23.7%, and 23.7%, respectively. CONCLUSION: Interventional protocol is safe, feasible, and efficacious for treatment of complications after esophagojejunostomy. Hindawi 2019-12-01 /pmc/articles/PMC6913380/ /pubmed/31871443 http://dx.doi.org/10.1155/2019/1465301 Text en Copyright © 2019 Yonghua Bi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Bi, Yonghua
Li, Jindong
Yi, Mengfei
Yu, Zepeng
Han, Xinwei
Ren, Jianzhuang
Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
title Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
title_full Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
title_fullStr Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
title_full_unstemmed Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
title_short Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
title_sort interventional protocol for treatment of complications after esophagojejunostomy for esophagogastric carcinoma
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913380/
https://www.ncbi.nlm.nih.gov/pubmed/31871443
http://dx.doi.org/10.1155/2019/1465301
work_keys_str_mv AT biyonghua interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma
AT lijindong interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma
AT yimengfei interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma
AT yuzepeng interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma
AT hanxinwei interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma
AT renjianzhuang interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma